home / stock / pfe / pfe articles

PFE Articles, Pfizer Inc. - From 03/06/24

Stock Information
Company Name: Pfizer Inc.
Stock Symbol: PFE
Market: NYSE
Website: pfizer.com
Menu
PFE PFE Quote PFE Short PFE News PFE Articles PFE Message Board
Get PFE Alerts

News, Short Squeeze, Breakout and More Instantly...
Injectable HIV Treatment By ViiV Healthcare Outperforms Oral Therapy, Interim Data Shows | Benzinga

ViiV Healthcare, majority owned by GSK Plc (NYSE:GSK), with Pfizer Inc (NYSE:PFE) and Shionogi Limited as shareholder...
What's Going On With Pfizer Stock Wednesday? | Benzinga

Pfizer Inc (NYSE:PFE) shares are trading higher Wednesday, bouncing back after the stock hit its lowest levels in more than 10 years this week. Her...

Josh Brown Just Bought This Stock Trading At 11-Year Lows, Paying A 6.5% Dividend: 'They Always Find A Way To Rebuild' | Benzinga

Ritholtz Wealth Management's Josh Brown believes the best opportunity in the market right now is in a pharmaceutical stock that’s t...

Pfizer/GSK-Backed ViiV Healthcare's HIV Drug Associated With Increased Resistance, WHO Report Says | Benzinga

The World Health Organization (WHO) released its latest HIV Drug Resistance (HIVDR) Report, shedding light on the growing areas of drug r...
Crucial Battle Over Healthcare Mandates: Biden Administration Defends Preventive Care Coverage Amidst Legal Challenges | Benzinga

The Biden administration is working to preserve a crucial federal mandate compelling health insurers to cover preventive care services, including ...

Pfizer's Respiratory Syncytial Virus Vaccine Maintains Staying Power In Older Adults Through 2nd RSV season, Study Finds | Benzinga

Thursday, Pfizer Inc (NYSE:PFE) announced top-line Abrysvo vaccine efficacy and safety data for respiratory syncytial virus (RSV) in adul...

Global Cancer Cachexia Market Size is Estimated to Reach USD 4.74 billion by 2031, Growing at a CAGR of 4.7%: Straits Research | Benzinga

New York, United States, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Increasing Prevalence of Cancer Cachexia to Drive the Global Cancer Cachexia Market A...
Amgen's Upcoming Catalysts In 2024 Set To Unlock Multi-Billion Dollar Markets, Says Goldman Sachs | Benzinga

Amgen Inc (NASDAQ:AMGN) is expected to unveil updates on various programs this year, targeting significant markets.  Despite concern...

Eli Lilly, Novo Nordisk's Strategies Against New Weight-Loss Drug Competitors | Benzinga

The race for new drugs to fight obesity and associated diabetes and cardiovascular diseases heated up on Monday after positive results from trials ...

Pfizer's Mixed Bag: A Look At The Fourth Quarter 2023 Earnings Call - Main Takeaways | Benzinga

Pfizer Inc. (NYSE: PFE) recently held its fourth-quarter earnings call, revealing a year of contrasts for the pharmaceutical giant. While the compa...
Previous 10 Next 10